The products will be launched on the market in the coming two months.
Some 10-12 percent of Sintofarm sales are made through the Centrofarm chain, whose national expansion could drive turnover up over 20 percent.
The pharmaceutical market has manifested an acute need for brands. Building a brand requires significant investment, and while some companies have the funds, they lack the time required to build a brand, thus opting to buy one.
Strongest brands on the local market are Algocalmin and Antinevralgic analgesics, which make over €10 million annually for Czech Zentiva owner.
